dipropylacetamide has been researched along with Pregnancy in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araujo, M; Benevent, J; Damase-Michel, C; Durrieu, G; Foch, C; Lacroix, I; Montastruc, JL; Weckel, A | 1 |
Hales, BF; Paradis, FH | 1 |
Aoki, Y; Bialer, M; Fujiwara, M; Kurihara, H; Kushima, K; Okada, A | 1 |
Aoki, Y; Bialer, M; Fujiwara, M; Kushima, K; Okada, A | 1 |
Bialer, M; Ehlers, K; Nau, H; Radatz, M; Yagen, B | 1 |
Giuliani, L; Oesch, F; Pacifici, GM; Rane, A; Temellini, A; Thomas, H | 1 |
Kerr, BM; Levy, RH | 1 |
Bertilsson, L; Pacifici, GM; Rane, A; Tomson, T | 1 |
8 other study(ies) available for dipropylacetamide and Pregnancy
Article | Year |
---|---|
In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Case-Control Studies; Child, Preschool; Databases, Factual; Female; France; Glucocorticoids; Hearing Loss; Humans; Male; Otitis Media; Pregnancy; Prenatal Exposure Delayed Effects; Valproic Acid | 2018 |
Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid-organogenesis mouse limbs.
Topics: Animals; Blotting, Western; Cells, Cultured; Chondrogenesis; Core Binding Factor Alpha 1 Subunit; Dose-Response Relationship, Drug; Female; Forelimb; Gene Expression Regulation, Developmental; Histone Deacetylase Inhibitors; Histone Deacetylases; Limb Buds; Limb Deformities, Congenital; Mice; Mice, Inbred Strains; Organogenesis; Osteogenesis; Pregnancy; Prenatal Exposure Delayed Effects; Real-Time Polymerase Chain Reaction; SOXB1 Transcription Factors; Valproic Acid | 2013 |
Polycomb homologs are involved in teratogenicity of valproic acid in mice.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Bone and Bones; DNA-Binding Proteins; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Gene Silencing; Histone-Lysine N-Methyltransferase; Injections, Subcutaneous; Male; Mice; Myeloid-Lymphoid Leukemia Protein; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Pregnancy; Proto-Oncogenes; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Valproic Acid; Zinc Fingers | 2004 |
Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Embryo, Mammalian; Female; Gene Expression; Gene Expression Profiling; Immediate-Early Proteins; Mice; Neural Tube Defects; Oligonucleotide Array Sequence Analysis; Pregnancy; Valproic Acid | 2005 |
Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Body Weight; Embryo, Mammalian; Female; Fetal Death; Mice; Mice, Inbred Strains; Pentanoic Acids; Pregnancy; Teratogens; Valproic Acid | 1998 |
Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
Topics: Anticonvulsants; Cytosol; Epoxide Hydrolases; Female; Fetus; Humans; In Vitro Techniques; Liver; Pregnancy; Stilbenes; Valproic Acid | 1989 |
Inhibition of epoxide hydrolase by anticonvulsants and risk of teratogenicity.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Drug Interactions; Epoxide Hydrolases; Female; Humans; Infant, Newborn; Microsomes, Liver; Pregnancy; Valproic Acid | 1989 |
Valpromide/carbamazepine and risk of teratogenicity.
Topics: Abnormalities, Drug-Induced; Animals; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant, Newborn; Macaca mulatta; Pregnancy; Valproic Acid | 1985 |